Asia Pacific Disposable Endoscopes Market Size, Share, Growth, Trends | Report 2022-2030
The Asia Pacific disposable endoscopes market was valued at USD 495.4 million in 2021 and it is predicted to surpass around USD 2.6 billion by 2030 with a CAGR of 20.23% from 2022 to 2030
Report Highlights
his growth can be attributed to the growing cases of contamination due to reusable endoscopes, increasing respiratory & chronic diseases, and the rise in the number of endoscopic procedures in the region. Furthermore, the unique selling propositions of disposable endoscopes, such as cost-effectiveness and lower chances of contamination, are also anticipated to drive the adoption of the product.
By application, the highest revenue share of around 29% was held by the bronchoscopy segment in 2021. This can be attributed to the growing preference and adoption of disposable bronchoscopes & their components for the removal of foreign substances & blockages from the airways or lungs. The lack of skilled professionals for cleaning and disinfecting reusable bronchoscopes is also anticipated to support the adoption of disposable units for lung disorder procedures. In addition, increasing mortality due to lung disorders is also expected to accelerate segment growth over the forecast period.
By end-use, the hospital segment is expected to hold a high revenue share of over 47% in 2021 owing to the increasing number of endoscopic procedures performed in hospitals and growing patient preference for early disease diagnosis. In addition, favorable reimbursement policies and low procedural costs of government hospitals also boosted the growth of the segment in the global market. However, the fastest growth rate is anticipated from the clinics segment due to the high preference for use of disposable endoscopes & components in these centers due to low postprocedural complications & quick recovery time.
The COVID-19 pandemic has positively impacted the adoption of single-use endoscopes. The rise in fear of contracting coronavirus infection has fueled the adoption of single-use endoscopic devices along with other disposable equipment. Several hospitals and clinics in the Asia Pacific region, performing endoscopic procedures, turned to disposable units to lower postprocedural complications and improve patient engagement during the pandemic. In addition, the continued lockdown and shortage of medical staff due to the COVID-19 infection also hampered the reprocessing of reusable endoscopes, thereby supporting the adoption of single-use devices.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 495.4 million |
| Revenue Forecast by 2030 | USD 2.6 billion |
| Growth rate from 2022 to 2030 | CAGR of 20.23% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Application, end-use, region |
| Companies Covered | Ambu A/S; Prosurg Inc. (Neoscape, Inc.); AirStrip Technologies; Boston Scientific Corporation; Parburch Medical; OBP Medical Corporation; Welch Allyn (Hill-Rom Services Inc.); Allscripts Healthcare Solutions; Flexicare Medical Limited; Timesco Healthcare Ltd.; Sunmed |
Application Insights
By application, the bronchoscopy segment dominated with a revenue share of around 29.2% in 2021. This high share of the segment can be attributed to the growing prevalence of respiratory diseases in Asia Pacific. Furthermore, the growing prevalence of pulmonary hypertension, Chronic Obstructive Pulmonary Disease (COPD), respiratory allergies, asthma, occupational lung disease, and infections caused by the use of reusable bronchoscopes supported the adoption of disposable bronchoscopes in the region.
Furthermore, technological advancements and the growing adoption of ear, nose, & throat endoscopic procedures, coupled with increasing concern about infections due to the use of reusable ENT endoscopes, are expected to support the growth of the segment. The growing prevalence of sinus infections, asthma, obstructive pulmonary disease (COPD), and respiratory allergies increases the number of endoscopic procedures, which is thereby anticipated to drive the market growth during the forecast period.
End-use Insights
By end-use, the hospital segment accounted for the highest revenue share of over 47.3% in 2021. This revenue share can be attributed to the increasing number of endoscopic procedures performed in hospitals and the growing patient preference for hospitals for the diagnosis of diseases. In addition, the growing number of modern hospitals in Asia Pacific with facilities for endoscopy, the cost-effectiveness of using disposable endoscopes & their components, and favorable reimbursement policies are also anticipated to fuel the growth of the segment.
The growing adoption of disposable endoscopic devices by clinics for better patient engagement is anticipated to drive segment growth over the forecast period. In addition, low maintenance costs & lower chances of contamination of single-use endoscopic devices, and advantages such as quick recovery time, cost-effectiveness, & shorter clinical stay are also expected to accelerate segment growth over the forecast period.
Regional Insights
Japan is anticipated to have a high revenue share of about 38.06% in 2021 in the Asia Pacific region owing to the growing adoption of single-use endoscopes and an increase in the number of endoscopic procedures. In addition, the growing prevalence of communicable & noncommunicable diseases and the rise in government initiatives for use of disposable endoscopes to minimize the chances of contamination are also anticipated to drive the Japanese market in this region.
Furthermore, the market in China is also expected to grow at a fast CAGR during the forecast period, owing to increasing awareness about reducing contamination due to reusable endoscopes as well as improving healthcare infrastructure. In addition, the high overall population; the growing geriatric population, which is prone to several chronic disorders; the increasing number of global & local endoscopic device manufacturers & their growing focus on the development of disposable endoscopes are further anticipated to drive market growth in China during the forecast period.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Asia Pacific Disposable Endoscopes Market
5.1. COVID-19 Landscape: Asia Pacific Disposable Endoscopes Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Asia Pacific Disposable Endoscopes Market, By Application
8.1. Asia Pacific Disposable Endoscopes Market, by Application, 2022-2030
8.1.1. Bronchoscopy
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Urologic endoscopy
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Arthroscopy
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. GI endoscopy
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. ENT endoscopy
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Asia Pacific Disposable Endoscopes Market, By End-use
9.1. Asia Pacific Disposable Endoscopes Market, by End-use, 2022-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Clinics
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Diagnostics Centers
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Asia Pacific Disposable Endoscopes Market, Regional Estimates and Trend Forecast
10.1. APAC
10.1.1. Market Revenue and Forecast, by Application (2017-2030)
10.1.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.3. India
10.1.3.1. Market Revenue and Forecast, by Application (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.4. China
10.1.4.1. Market Revenue and Forecast, by Application (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.5. Japan
10.1.5.1. Market Revenue and Forecast, by Application (2017-2030)
10.1.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.6. Rest of APAC
10.1.6.1. Market Revenue and Forecast, by Application (2017-2030)
10.1.6.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 11. Company Profiles
11.1. Ambu A/S
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Prosurg Inc. (Neoscape, Inc.)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. AirStrip Technologies
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Boston Scientific Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Parburch Medical
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. OBP Medical Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Welch Allyn (Hill-Rom Services Inc.)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Allscripts Healthcare Solutions
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Flexicare Medical Limited
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Timesco Healthcare Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers